{"title":"Attitudes of anabolic steroid users and non-users towards general practitioners in the United Kingdom","authors":"","doi":"10.1016/j.peh.2024.100304","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Research from past decades has suggested that anabolic-androgenic steroid (AAS) users are often sceptical of their physicians’ level of knowledge regarding AAS. We questioned whether contemporary British AAS users and non-AAS-using weightlifters would display similar distrust of their general practitioners.</div></div><div><h3>Methods</h3><div>We distributed anonymous questionnaires to 61 AAS-using and 106 non-AAS-using male British weightlifters at gymnasiums and via online social media sites. Respondents rated their general practitioners’ knowledge regarding health- and drug-related topics, using 10-point Likert scales from 0 (worst) to 10 (best). AAS users also rated their degree of trust in various sources of information about AAS, using similar scales, and were asked whether they had disclosed their AAS use to various categories of individuals. We then compared our findings with the results from a 2004 American study that had used virtually identical methodology.</div></div><div><h3>Results</h3><div>Both AAS-using and non-using weightlifters rated their general practitioners favourably on knowledge of general health and disease, cigarette smoking, and alcohol, with mean scores ranging from 6.8 to 8.7. However, respondents scored their general practitioners significantly lower on knowledge of AAS, with mean ratings of 4.3 to 4.9 from AAS non-users and only 2.4 to 2.9 from users. Among various sources of information about AAS, users trusted their doctors significantly less than “underground” guides or Internet sites. Only 22 (36 %) of the AAS users had ever disclosed their use of these drugs to any physician. These findings closely resembled those of the earlier American study, with contemporary British men reporting even greater mistrust of their physicians on weightlifting- and AAS-related topics than their American counterparts.</div></div><div><h3>Conclusion</h3><div>Despite increasing AAS use worldwide and mounting evidence of the long-term dangers of these drugs, contemporary British weightlifters in general and AAS users in particular appear to remain distrustful of their physicians’ knowledge of fitness sports, performance-enhancing supplements, and especially AAS.</div></div>","PeriodicalId":19886,"journal":{"name":"Performance enhancement and health","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Performance enhancement and health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211266924000501","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HOSPITALITY, LEISURE, SPORT & TOURISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Research from past decades has suggested that anabolic-androgenic steroid (AAS) users are often sceptical of their physicians’ level of knowledge regarding AAS. We questioned whether contemporary British AAS users and non-AAS-using weightlifters would display similar distrust of their general practitioners.
Methods
We distributed anonymous questionnaires to 61 AAS-using and 106 non-AAS-using male British weightlifters at gymnasiums and via online social media sites. Respondents rated their general practitioners’ knowledge regarding health- and drug-related topics, using 10-point Likert scales from 0 (worst) to 10 (best). AAS users also rated their degree of trust in various sources of information about AAS, using similar scales, and were asked whether they had disclosed their AAS use to various categories of individuals. We then compared our findings with the results from a 2004 American study that had used virtually identical methodology.
Results
Both AAS-using and non-using weightlifters rated their general practitioners favourably on knowledge of general health and disease, cigarette smoking, and alcohol, with mean scores ranging from 6.8 to 8.7. However, respondents scored their general practitioners significantly lower on knowledge of AAS, with mean ratings of 4.3 to 4.9 from AAS non-users and only 2.4 to 2.9 from users. Among various sources of information about AAS, users trusted their doctors significantly less than “underground” guides or Internet sites. Only 22 (36 %) of the AAS users had ever disclosed their use of these drugs to any physician. These findings closely resembled those of the earlier American study, with contemporary British men reporting even greater mistrust of their physicians on weightlifting- and AAS-related topics than their American counterparts.
Conclusion
Despite increasing AAS use worldwide and mounting evidence of the long-term dangers of these drugs, contemporary British weightlifters in general and AAS users in particular appear to remain distrustful of their physicians’ knowledge of fitness sports, performance-enhancing supplements, and especially AAS.